BrainsWay makes Deep TMS magnetic brain stimulation systems used to treat mental health disorders. BWAY reports earnings on Tue, Nov 10, 2026. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell).
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Aug 31 | HC Wainwright & Co. | Target raised | Buy | |
| Aug 13 | Ladenburg Thalmann | Maintained | Buy | |
| Aug 12 | BTIG | Target raised | Buy | |
| Jul 20 | BTIG | Initiated | Buy | |
| Jul 2 | HC Wainwright & Co. | Reiterated | Buy |
Seasonality
How BWAY has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.
Whale Options Flow
90DNo whale options trades in BWAY in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BWAY is in one of them and how their past BWAY trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered BWAY in an article yet. Here's the latest on the wider market.
About Brainsway
BrainsWay is a medical technology company based in Jerusalem, Israel. It makes Deep TMS systems, which use magnetic pulses to stimulate brain regions in a noninvasive way to treat mental health conditions. The treatments are cleared in the United States for depression, including anxious depression, and obsessive-compulsive disorder, and the company markets them for smoking addiction. It sells its systems to psychiatrists' offices and other treatment facilities that care for these patients.
- Headquarters
- Jerusalem, Israel
- Founded
- 2003
- Website
- brainsway.com ↗